-
The different drug formulations of menopausal hormone therapy (HT) may determine the risk of venous thromboembolism (VTE), according to a new study.
-
The National Survey of Family Growth (NSFG) is a national representative survey designed to provide data that supplement and complement the National Vital Statistics by collecting information on the factors that affect birth rates including sexual activity, marriage, divorce, cohabitation, contraceptive use, and infertility.
-
Women with HIV have a higher incidence of cervical intraepithelial neoplasia (CIN) because of the burden and persistence of HPV in that population.
-
Ever since stuart campbell introduced the concept of using ultrasound waveforms of the uterine artery to screen for preeclampsia (PE), single studies and meta-analyses have emerged to address its efficacy with inconsistent results.
-
To evaluate the impact of surgical staging on survival of women with early stage (Stage IA and Stage IB) uterine papillary serous cancer (USC), a retrospective analysis was undertaken on patients treated over a 15-year period at two institutions. Over this time period, 84 cases of early stage cancer were identified.
-
The authors performed a prospective cohort study, the contraceptive CHOICE Project, in which women in the St. Louis, Missouri, region received a reversible contraceptive method of their choice for up to 3 years at no cost.
-
Apropos of the recent emphasis on discouraging elective deliveries prior to 39 weeks, a group from Cincinnati embarked on a study to determine whether steroids had any neonatal benefit in patients delivering between 34 and 39 weeks who had immature amniotic fluid lung profiles.
-
In this issue: Lorcaserin for weight loss; statins and fatigue; treatment-resistant gonorrhea; hydrocodone classification changes; USPSTF recommendations; and FDA actions.
-
Researchers from duke university and the university of California, San Francisco enrolled 40 patients with symptoms of overactive bladder (OAB), i.e., urgency, frequency, and/or urge incontinence, and 40 patients with no history of OAB symptoms. The women's view of symptoms and treatments were measured with a utility score.
-
